Galectin Therapeutics, Inc. (GALT)
4.31
-0.07
(-1.60%)
USD |
NASDAQ |
Dec 22, 10:05
Galectin Therapeutics Market Cap: 277.88M for Dec. 22, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 714.48M |
| Palatin Technologies, Inc. | 15.70M |
| Theriva Biologics, Inc. | 6.380M |
| Oragenics, Inc. | 0.7223M |
| NanoViricides, Inc. | 22.23M |
Market Cap Related Metrics
| Price | 4.31 |
| Earnings Yield | -13.72% |